Product Program year 2020 Source: CMS Open Payments

Nanostim Leadleas Pacemaker

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$312,039

359 payments

Research payments

$0

0 payments

Through program year 2020, $312,039 in general payments and $0 in research payments were reported against Nanostim Leadleas Pacemaker (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $168,038 182
2019 General $144,001 177

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $312,039 359 payments
Top recipients General payments · program year 2020
  1. Raul Weiss Clinical Cardiac Electrophysiology · Miami Beach, FL $51,713 31% · 20 payments
  2. Stephen Fahrig Clinical Cardiac Electrophysiology · Nashville, TN $38,690 23% · 28 payments
  3. Mayer Rashtian Clinical Cardiac Electrophysiology · Pasadena, CA $9,216 5% · 8 payments
  4. Monica Lo Clinical Cardiac Electrophysiology · Little Rock, AR $8,263 5% · 10 payments
  5. Joshua Cooper Clinical Cardiac Electrophysiology · Philadelphia, PA $7,800 5% · 6 payments

The top 5 of 41 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Clinical Cardiac Electrophysiology Internal Medicine $147,098 88% · 26 practitioners
  2. Cardiovascular Disease Internal Medicine $10,905 6% · 6 practitioners
  3. Pain Medicine Physical Medicine & Rehabilitation $5,872 3% · 1 practitioner
  4. Diagnostic Radiology Radiology $2,000 1% · 1 practitioner
  5. Internal Medicine $863 <1% · 2 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Ohio $56,913 34% · 4 recipients
  2. California $44,065 26% · 14 recipients
  3. Tennessee $38,737 23% · 2 recipients
  4. Pennsylvania $8,809 5% · 3 recipients
  5. Arkansas $8,263 5% · 1 recipient

The top 5 of 16 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

359 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record